117 related articles for article (PubMed ID: 8393164)
21. Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta.
Ziegler SF; Bird TA; Schneringer JA; Schooley KA; Baum PR
Oncogene; 1993 Mar; 8(3):663-70. PubMed ID: 8382358
[TBL] [Abstract][Full Text] [Related]
22. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade.
Davis-Smyth T; Chen H; Park J; Presta LG; Ferrara N
EMBO J; 1996 Sep; 15(18):4919-27. PubMed ID: 8890165
[TBL] [Abstract][Full Text] [Related]
23. Isolation of a gene encoding a novel receptor tyrosine kinase from differentiated embryonic stem cells.
Choi K; Wall C; Hanratty R; Keller G
Oncogene; 1994 Apr; 9(4):1261-6. PubMed ID: 8134130
[TBL] [Abstract][Full Text] [Related]
24. Molecular cloning of the cDNA encoding a receptor tyrosine kinase-related molecule with a catalytic region homologous to c-met.
Paul SR; Merberg D; Finnerty H; Morris GE; Morris JC; Jones SS; Kriz R; Turner KJ; Wood CR
Int J Cell Cloning; 1992 Sep; 10(5):309-14. PubMed ID: 1333503
[TBL] [Abstract][Full Text] [Related]
25. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
[TBL] [Abstract][Full Text] [Related]
26. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
27. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
[TBL] [Abstract][Full Text] [Related]
28. Soluble Flt-1 (soluble VEGFR-1), a potent natural antiangiogenic molecule in mammals, is phylogenetically conserved in avians.
Yamaguchi S; Iwata K; Shibuya M
Biochem Biophys Res Commun; 2002 Mar; 291(3):554-9. PubMed ID: 11855824
[TBL] [Abstract][Full Text] [Related]
29. Rapid isolation of cell-type-specific protein tyrosine kinases by degenerate polymerase chain reaction combined with differential hybridization technique.
Kim SJ; Sasaki H; Takahashi A; Katoh M; Kakizoe T; Kim YK; Sugimura T; Terada M
Biochem Biophys Res Commun; 1995 Sep; 214(1):60-8. PubMed ID: 7669053
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells.
Frank S; Stallmeyer B; Kämpfer H; Schaffner C; Pfeilschifter J
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):367-74. PubMed ID: 10024512
[TBL] [Abstract][Full Text] [Related]
31. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.
Ahmed A; Dunk C; Kniss D; Wilkes M
Lab Invest; 1997 Jun; 76(6):779-91. PubMed ID: 9194854
[TBL] [Abstract][Full Text] [Related]
32. The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4).
Gallahan D; Callahan R
Oncogene; 1997 Apr; 14(16):1883-90. PubMed ID: 9150355
[TBL] [Abstract][Full Text] [Related]
33. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family.
He WW; Gustafson ML; Hirobe S; Donahoe PK
Dev Dyn; 1993 Feb; 196(2):133-42. PubMed ID: 8395914
[TBL] [Abstract][Full Text] [Related]
34. Identification of the extracellular domains of Flt-1 that mediate ligand interactions.
Cunningham SA; Stephan CC; Arrate MP; Ayer KG; Brock TA
Biochem Biophys Res Commun; 1997 Feb; 231(3):596-9. PubMed ID: 9070853
[TBL] [Abstract][Full Text] [Related]
35. Cloning and functional characterization of the chicken c-ros promoter.
Chen J; Tong J; Tanaka-Sukegawa I; Wang LH
Cell Growth Differ; 1995 Dec; 6(12):1523-30. PubMed ID: 9019157
[TBL] [Abstract][Full Text] [Related]
36. Cloning and characterization of the murine toll-like receptor 5 (Tlr5) gene: sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice.
Sebastiani G; Leveque G; Larivière L; Laroche L; Skamene E; Gros P; Malo D
Genomics; 2000 Mar; 64(3):230-40. PubMed ID: 10756091
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.
Whittle C; Gillespie K; Harrison R; Mathieson PW; Harper SJ
Clin Sci (Lond); 1999 Sep; 97(3):303-12. PubMed ID: 10464055
[TBL] [Abstract][Full Text] [Related]
38. Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites.
Cunningham SA; Arrate MP; Brock TA; Waxham MN
Biochem Biophys Res Commun; 1997 Nov; 240(3):635-9. PubMed ID: 9398617
[TBL] [Abstract][Full Text] [Related]
39. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Apr; 15(7):1751. PubMed ID: 8612600
[No Abstract] [Full Text] [Related]
40. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
Barleon B; Siemeister G; Martiny-Baron G; Weindel K; Herzog C; Marmé D
Cancer Res; 1997 Dec; 57(23):5421-5. PubMed ID: 9393770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]